ZYDUS PHARMS USA INC FDA Approval ANDA 213345

ANDA 213345

ZYDUS PHARMS USA INC

FDA Drug Application

Application #213345

Application Sponsors

ANDA 213345ZYDUS PHARMS USA INC

Marketing Status

None (Tentative Approval)001

FDA Submissions

UNKNOWN; ORIG1TA2020-09-08STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

ZYDUS PHARMS USA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213345
            [companyName] => ZYDUS PHARMS USA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"EMPAGLIFLOZIN; LINAGLIPTIN","activeIngredients":"EMPAGLIFLOZIN;LINAGLIPTIN","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/08\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-09-08
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.